Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIG Regulatory News (SHI)

Share Price Information for SIG (SHI)

Share Price is delayed by 15 minutes
Get Live Data
8.35    0.34 (4.24%)
Bid:
8.02
Ask:
8.12
Spread: 0.10 (1.247%)
Market Cap: £96.51m
SHI Live PriceLast checked at - London Stock Exchange

Intraday SIG Share Chart

Short Selling Disclosure: Form TR-3

19 Mar 2009 14:24

Form TR-3. FSA Version 1.0 June 2008

TR-3 (1): Disclosure of Disclosable Short Position relating to Securities

which are the subject of a rights issue (2)

1. Full name of person(s) holding Sirios Capital Management, L.P. the disclosable short position (3):

2: Name of the issuer of the relevant SIG Plc securities 3: Disclosable short position (4) 0.64% 4. Date that disclosable short position 18th March 2009 was reached or exceeded

(1) This form, or the information contained within it, should be disclosed via an RIS using the short code DSP. Issuers should conform the commencement of the rights issuer period with a disclosure, via an RIS, using the short code ARI.

(2) This form relates to the disclosure of short positions in compliance with amendments to MAR 1.9 market abuse (misleading behaviour) and market abuse (distortion) of the Market Conduct Sourcebook (MAR). Further material on this can be found in the FSA's press release of 13 June 2008, http://www.fsa.gov.uk/ pages/Library/Communication/PR/2008/057.shtml and the related FAQ document on the FSA's website.

(3) Specify the owner or controller of the interest. The naming of nominees or vehicle companies is insufficient. In the case of positions held by fund managers on behalf of discretionary clients, the clients need not be named. Market makers as defined in the Glossary of Definitions in the FSA Handbook and acting in their capacity as such may be exempt from disclosure of own account positions: see the definition of "disclosable short position". Positions may be aggregated in some cases. See FAQ document for further details.

(4) Figure to be expressed as a percentage of issued share capital. Disclosable short position is defined in the Glossary of Definitions in the FSA Handbook. Positions must be disclosed on a net basis of all holdings. All financial instruments that represent a direct interest or direct economic interest in the relevant issuer must be included within such holdings.

vendor
Date   Source Headline
8th Jun 20264:44 pmRNSDirector/PDMR Shareholding
3rd Jun 20263:50 pmRNSDirector/PDMR Shareholding
28th May 20262:56 pmRNSDirector/PDMR Shareholding
22nd May 20261:36 pmRNSDirector/PDMR Shareholding
22nd May 20261:29 pmRNSDirector/PDMR Shareholding
22nd May 20261:18 pmRNSResult of Meeting
20th May 20263:07 pmRNSDirector/PDMR Shareholding
14th May 20264:44 pmRNSDirector/PDMR Shareholding
13th May 20265:27 pmRNSDirector/PDMR Shareholding
6th May 202611:11 amRNSDirector/PDMR Shareholding
6th May 202610:24 amRNSNotice of GM
30th Apr 20262:00 pmRNSResult of AGM
30th Apr 20267:01 amRNSTrading Update
30th Apr 20267:00 amRNSAppointment of Chief Financial Officer
10th Apr 20267:00 amRNSDirectorate change
23rd Mar 202610:57 amRNSDirector/PDMR Shareholding
23rd Mar 20269:59 amRNSNotice of AGM
4th Mar 202610:18 amRNSAnnual Financial Report
4th Mar 20267:00 amRNSFull year results for year ended 31 December 2025
15th Jan 20264:02 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNS2025 Full Year Trading Update & Strategy Framework
19th Dec 20257:00 amRNSNotice of Trading & Business Update
19th Dec 20257:00 amRNSNotice of Trading & Business Update
23rd Oct 202511:05 amRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSQ3 Trading Update
1st Oct 20259:00 amRNSDirector/PDMR Shareholding
3rd Sep 202510:54 amRNSHolding(s) in Company
28th Aug 20251:02 pmRNSResult of Meeting
8th Aug 202511:01 amRNSNotice of GM
5th Aug 20257:00 amRNSResults for the six months to 30 June 2025
8th Jul 20257:01 amRNSAppointment of CEO and Chair designate
8th Jul 20257:00 amRNSH1 Trading Update
9th May 20257:00 amRNSDirectorate Change
6th May 20253:00 pmRNSHolding(s) in Company
1st May 20253:12 pmRNSResult of AGM
30th Apr 20257:00 amRNSTrading Update
10th Apr 20254:02 pmRNSDirector/PDMR Shareholding
4th Apr 202511:10 amRNSDirector/PDMR Shareholding
1st Apr 20254:00 pmRNSHolding(s) in Company
28th Mar 20255:03 pmRNSDirector/PDMR Shareholding
28th Mar 20254:59 pmRNSDirector/PDMR Shareholding
24th Mar 202510:06 amRNSNotice of AGM
21st Mar 20254:44 pmRNSDirector/PDMR Shareholding
12th Mar 20259:06 amRNSDirector/PDMR Shareholding
12th Mar 20258:54 amRNSDirectorate Change
10th Mar 20258:32 amRNSDirector/PDMR Shareholding
5th Mar 202511:17 amRNSAnnual Financial Report
5th Mar 20257:00 amRNSFull year results for year ended 31 December 2024
4th Mar 202512:52 pmRNSHolding(s) in Company
19th Feb 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.